From Models to Molecules: Opioid Receptor Dimers, Bivalent Ligands, and Selective Opioid Receptor Probes
- 23 May 2001
- journal article
- special topics
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (14) , 2259-2269
- https://doi.org/10.1021/jm010158+
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Isosteric Replacement of Acidic with Neutral Residues in Extracellular Loop-2 of the κ-Opioid Receptor Does Not Affect Dynorphin A(1−13) Affinity and FunctionJournal of Medicinal Chemistry, 2000
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Opioid Antagonist Activity of Naltrexone-Derived Bivalent Ligands: Importance of a Properly Oriented Molecular Scaffold To Guide “Address” Recognition at κ Opioid ReceptorsJournal of Medicinal Chemistry, 1996
- Selective Natrexone-Derived Opioid Receptor AntagonistsAnnual Review of Pharmacology and Toxicology, 1992
- 3-Phenoxypyridine 1-oxides as anticonvulsant agentsJournal of Medicinal Chemistry, 1988
- Synthesis and biological activity of analogs of .beta.-chlornaltrexamine and .beta.-funaltrexamine at opioid receptorsJournal of Medicinal Chemistry, 1986
- Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different .mu. receptor subtypes in different tissuesJournal of Medicinal Chemistry, 1984
- Different receptor sites mediate opioid agonism and antagonismJournal of Medicinal Chemistry, 1983
- Opioid agonist and antagonist bivalent ligands as receptor probesLife Sciences, 1982
- Comments on the optical and radio detection of black hole explosionsNature, 1977